Contributors



We acknowledge the following contributors:


  1. Ryu JW, Kim HJ, Lee YS, Myong NH, Hwang CH, Lee GS, Yom HC. The proteomics approach to find biomarkers in gastric cancer. J Korean Med Sci. 2003 Aug;18(4):505-9. doi: 10.3346/jkms.2003.18.4.505. PMID: 12923326; PMCID: PMC3055082.
  2. Baek HY, Lim JW, Kim H, Kim JM, Kim JS, Jung HC, Kim KH. Oxidative-stress- related proteome changes in Helicobacter pylori-infected human gastric mucosa. Biochem J. 2004 Apr 15;379(Pt 2):291-9. doi: 10.1042/BJ20031208. PMID: 14711373; PMCID: PMC1224076.
  3. He QY, Cheung YH, Leung SY, Yuen ST, Chu KM, Chiu JF. Diverse proteomic alterations in gastric adenocarcinoma. Proteomics. 2004 Oct;4(10):3276-87. doi: 10.1002/pmic.200300916. PMID: 15378696.
  4. Lee K, Kye M, Jang JS, Lee OJ, Kim T, Lim D. Proteomic analysis revealed a strong association of a high level of alpha1-antitrypsin in gastric juice with gastric cancer. Proteomics. 2004 Nov;4(11):3343-52. doi: 10.1002/pmic.200400960. PMID: 15378737.
  5. Jang JS, Cho HY, Lee YJ, Ha WS, Kim HW. The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol Res. 2004;14(10):491-9. doi: 10.3727/0965040042380441. PMID: 15559763.
  6. Lee CH, Lum JH, Cheung BP, Wong MS, Butt YK, Tam MF, Chan WY, Chow C, Hui PK, Kwok FS, Lo SC, Fan DM. Identification of the heterogeneous nuclear ribonucleoprotein A2/B1 as the antigen for the gastrointestinal cancer specific monoclonal antibody MG7. Proteomics. 2005 Mar;5(4):1160-6. doi: 10.1002/pmic.200401159. PMID: 15759317.
  7. Greengauz-Roberts O, Stöppler H, Nomura S, Yamaguchi H, Goldenring JR, Podolsky RH, Lee JR, Dynan WS. Saturation labeling with cysteine-reactive cyanine fluorescent dyes provides increased sensitivity for protein expression profiling of laser-microdissected clinical specimens. Proteomics. 2005 May;5(7):1746-57. doi: 10.1002/pmic.200401068. PMID: 15761955.
  8. Ebert MP, Krüger S, Fogeron ML, Lamer S, Chen J, Pross M, Schulz HU, Lage H, Heim S, Roessner A, Malfertheiner P, Röcken C. Overexpression of cathepsin B in gastric cancer identified by proteome analysis. Proteomics. 2005 Apr;5(6):1693-704. doi: 10.1002/pmic.200401030. PMID: 15789341.
  9. Ebert MP, Lamer S, Meuer J, Malfertheiner P, Reymond M, Buschmann T, Röcken C, Seibert V. Identification of the thrombin light chain a as the single best mass for differentiation of gastric cancer patients from individuals with dyspepsia by proteome analysis. J Proteome Res. 2005 Mar-Apr;4(2):586-90. doi: 10.1021/pr049771i. PMID: 15822938.
  10. Nishigaki R, Osaki M, Hiratsuka M, Toda T, Murakami K, Jeang KT, Ito H, Inoue T, Oshimura M. Proteomic identification of differentially-expressed genes in human gastric carcinomas. Proteomics. 2005 Aug;5(12):3205-13. doi: 10.1002/pmic.200401307. PMID: 16003825.
  11. Melle C, Ernst G, Schimmel B, Bleul A, Kaufmann R, Hommann M, Richter KK, Daffner W, Settmacher U, Claussen U, von Eggeling F. Characterization of pepsinogen C as a potential biomarker for gastric cancer using a histo-proteomic approach. J Proteome Res. 2005 Sep-Oct;4(5):1799-804. doi: 10.1021/pr050123o. PMID: 16212435.
  12. Ren H, Du N, Liu G, Hu HT, Tian W, Deng ZP, Shi JS. Analysis of variabilities of serum proteomic spectra in patients with gastric cancer before and after operation. World J Gastroenterol. 2006 May 7;12(17):2789-92. doi: 10.3748/wjg.v12.i17.2789. PMID: 16718772; PMCID: PMC4130994.
  13. Ebert MP, Niemeyer D, Deininger SO, Wex T, Knippig C, Hoffmann J, Sauer J, Albrecht W, Malfertheiner P, Röcken C. Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry. J Proteome Res. 2006 Sep;5(9):2152-8. doi: 10.1021/pr060011c. PMID: 16944926.
  14. Liu W, Liu B, Xin L, Zhang Y, Chen X, Zhu Z, Lin Y. Down-regulated expression of complement factor I: a potential suppressive protein for gastric cancer identified by serum proteome analysis. Clin Chim Acta. 2007 Feb;377(1-2):119-26. doi: 10.1016/j.cca.2006.09.005. Epub 2006 Sep 14. PMID: 17067565.
  15. Lim BH, Cho BI, Kim YN, Kim JW, Park ST, Lee CW. Overexpression of nicotinamide N-methyltransferase in gastric cancer tissues and its potential post-translational modification. Exp Mol Med. 2006 Oct 31;38(5):455-65. doi: 10.1038/emm.2006.54. PMID: 17079861.
  16. Bloom GC, Eschrich S, Zhou JX, Coppola D, Yeatman TJ. Elucidation of a protein signature discriminating six common types of adenocarcinoma. Int J Cancer. 2007 Feb 15;120(4):769-75. doi: 10.1002/ijc.22041. PMID: 17131332.
  17. Chen CD, Wang CS, Huang YH, Chien KY, Liang Y, Chen WJ, Lin KH. Overexpression of CLIC1 in human gastric carcinoma and its clinicopathological significance. Proteomics. 2007 Jan;7(1):155-67. doi: 10.1002/pmic.200600663. PMID: 17154271.
  18. Yoshihara T, Kadota Y, Yoshimura Y, Tatano Y, Takeuchi N, Okitsu H, Umemoto A, Yamauchi T, Itoh K. Proteomic alteration in gastic adenocarcinomas from Japanese patients. Mol Cancer. 2006 Dec 25;5:75. doi: 10.1186/1476-4598-5-75. PMID: 17187689; PMCID: PMC1774573.
  19. Hsu PI, Chen CH, Hsieh CS, Chang WC, Lai KH, Lo GH, Hsu PN, Tsay FW, Chen YS, Hsiao M, Chen HC, Lu PJ. Alpha1-antitrypsin precursor in gastric juice is a novel biomarker for gastric cancer and ulcer. Clin Cancer Res. 2007 Feb 1;13(3):876-83. doi: 10.1158/1078-0432.CCR-06-1404. PMID: 17289880.
  20. Li N, Zhang J, Liang Y, Shao J, Peng F, Sun M, Xu N, Li X, Wang R, Liu S, Lu Y. A controversial tumor marker: is SM22 a proper biomarker for gastric cancer cells? J Proteome Res. 2007 Aug;6(8):3304-12. doi: 10.1021/pr0702363. Epub 2007 Jul 13. PMID: 17629319.
  21. Chen SH, Liao HK, Chang CY, Juo CG, Chen JH, Chan SI, Chen YJ. Targeted protein quantitation and profiling using PVDF affinity probe and MALDI-TOF MS. Proteomics. 2007 Sep;7(17):3038-50. doi: 10.1002/pmic.200700393. PMID: 17676666.
  22. Cheng Y, Zhang J, Li Y, Wang Y, Gong J. Proteome analysis of human gastric cardia adenocarcinoma by laser capture microdissection. BMC Cancer. 2007 Oct 11;7:191. doi: 10.1186/1471-2407-7-191. PMID: 17927838; PMCID: PMC2151079.
  23. Zhang J, Kang B, Tan X, Bai Z, Liang Y, Xing R, Shao J, Xu N, Wang R, Liu S, Lu Y. Comparative analysis of the protein profiles from primary gastric tumors and their adjacent regions: MAWBP could be a new protein candidate involved in gastric cancer. J Proteome Res. 2007 Nov;6(11):4423-32. doi: 10.1021/pr0703425. Epub 2007 Oct 11. PMID: 17929853.
  24. Huang Q, Huang Q, Chen W, Wang L, Lin W, Lin J, Lin X. Identification of transgelin as a potential novel biomarker for gastric adenocarcinoma based on proteomics technology. J Cancer Res Clin Oncol. 2008 Nov;134(11):1219-27. doi: 10.1007/s00432-008-0398-y. Epub 2008 Apr 30. PMID: 18446369.
  25. Wang KY, Chuang SA, Lin PC, Huang LS, Chen SH, Ouarda S, Pan WH, Lee PY, Lin CC, Chen YJ. Multiplexed immunoassay: quantitation and profiling of serum biomarkers using magnetic nanoprobes and MALDI-TOF MS. Anal Chem. 2008 Aug 15;80(16):6159-67. doi: 10.1021/ac800354u. Epub 2008 Jul 22. PMID: 18642877.
  26. Liu R, Li Z, Bai S, Zhang H, Tang M, Lei Y, Chen L, Liang S, Zhao YL, Wei Y, Huang C. Mechanism of cancer cell adaptation to metabolic stress: proteomics identification of a novel thyroid hormone-mediated gastric carcinogenic signaling pathway. Mol Cell Proteomics. 2009 Jan;8(1):70-85. doi: 10.1074/mcp.M800195-MCP200. Epub 2008 Aug 22. PMID: 18723843.
  27. Jia SQ, Niu ZJ, Zhang LH, Zhong XY, Shi T, Du H, Zhang GG, Hu Y, Su XL, Ji JF. Identification of prognosis-related proteins in advanced gastric cancer by mass spectrometry-based comparative proteomics. J Cancer Res Clin Oncol. 2009 Mar;135(3):403-11. doi: 10.1007/s00432-008-0474-3. Epub 2008 Oct 1. PMID: 18830628.
  28. Li W, Li JF, Qu Y, Chen XH, Qin JM, Gu QL, Yan M, Zhu ZG, Liu BY. Comparative proteomics analysis of human gastric cancer. World J Gastroenterol. 2008 Oct 7;14(37):5657-64. doi: 10.3748/wjg.14.5657. PMID: 18837081; PMCID: PMC2748199.
  29. Kon OL, Yip TT, Ho MF, Chan WH, Wong WK, Tan SY, Ng WH, Kam SY, Eng AKh, Ho P, Viner R, Ong HS, Kumarasinghe MP. The distinctive gastric fluid proteome in gastric cancer reveals a multi-biomarker diagnostic profile. BMC Med Genomics. 2008 Oct 25;1:54. doi: 10.1186/1755-8794-1-54. PMID: 18950519; PMCID: PMC2584050.
  30. Bäckström M, Thomsson KA, Karlsson H, Hansson GC. Sensitive liquid chromatography-electrospray mass spectrometry allows for the analysis of the O-glycosylation of immunoprecipitated proteins from cells or tissues: application to MUC1 glycosylation in cancer. J Proteome Res. 2009 Feb;8(2):538-45. doi: 10.1021/pr800713h. PMID: 19072658.
  31. Zhang Z, Li M, Zhang G, Fang P, Yao H, Xiao Z, Chen Z. Identification of human gastric carcinoma biomarkers by differential protein expression analysis using 18O labeling and nanoLC-MS/MS coupled with laser capture microdissection. Med Oncol. 2010 Jun;27(2):296-303. doi: 10.1007/s12032-009-9208-x. Epub 2009 Mar 28. PMID: 19330469.
  32. Wu C, Luo Z, Chen X, Wu C, Yao D, Zhao P, Liu L, Shi B, Zhu L. Two- dimensional differential in-gel electrophoresis for identification of gastric cancer-specific protein markers. Oncol Rep. 2009 Jun;21(6):1429-37. doi: 10.3892/or_00000371. PMID: 19424620.
  33. Mohri Y, Mohri T, Wei W, Qi YJ, Martin A, Miki C, Kusunoki M, Ward DG, Johnson PJ. Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer. Br J Cancer. 2009 Jul 21;101(2):295-302. doi: 10.1038/sj.bjc.6605138. Epub 2009 Jun 23. PMID: 19550422; PMCID: PMC2720195.
  34. Tsunemi S, Nakanishi T, Fujita Y, Bouras G, Miyamoto Y, Miyamoto A, Nomura E, Takubo T, Tanigawa N. Proteomics-based identification of a tumor-associated antigen and its corresponding autoantibody in gastric cancer. Oncol Rep. 2010 Apr;23(4):949-56. doi: 10.3892/or_00000719. PMID: 20204278.
  35. Liu W, Gao X, Cai Q, Li J, Zhu Z, Li C, Yao X, Yang Q, Xiang M, Yan M, Zhu Z. Identification of novel serum biomarkers for gastric cancer by magnetic bead. Front Biosci (Elite Ed). 2010 Jun 1;2(3):961-71. doi: 10.2741/e155. PMID: 20515767.
  36. Kim HK, Reyzer ML, Choi IJ, Kim CG, Kim HS, Oshima A, Chertov O, Colantonio S, Fisher RJ, Allen JL, Caprioli RM, Green JE. Gastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry. J Proteome Res. 2010 Aug 6;9(8):4123-30. doi: 10.1021/pr100302b. Erratum in: J Proteome Res. 2011 Jan 7;10(1):361. PMID: 20557134; PMCID: PMC3441055.
  37. Cai Z, Zhao JS, Li JJ, Peng DN, Wang XY, Chen TL, Qiu YP, Chen PP, Li WJ, Xu LY, Li EM, Tam JP, Qi RZ, Jia W, Xie D. A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism. Mol Cell Proteomics. 2010 Dec;9(12):2617-28. doi: 10.1074/mcp.M110.000661. Epub 2010 Aug 10. PMID: 20699381; PMCID: PMC3101851.
  38. Chong PK, Lee H, Loh MC, Choong LY, Lin Q, So JB, Lim KH, Soo RA, Yong WP, Chan SP, Smoot DT, Ashktorab H, Yeoh KG, Lim YP. Upregulation of plasma C9 protein in gastric cancer patients. Proteomics. 2010 Sep;10(18):3210-21. doi: 10.1002/pmic.201000127. PMID: 20707004; PMCID: PMC3760195.
  39. Chang WC, Hsu PI, Chen YY, Hsiao M, Lu PJ, Chen CH. Observation of peptide differences between cancer and control in gastric juice. Proteomics Clin Appl. 2008 Jan;2(1):55-62. doi: 10.1002/prca.200780066. PMID: 21136779.
  40. Lin LL, Chen CN, Lin WC, Lee PH, Chang KJ, Lai YP, Wang JT, Juan HF. Annexin A4: A novel molecular marker for gastric cancer with Helicobacter pylori infection using proteomics approach. Proteomics Clin Appl. 2008 Apr;2(4):619-34. doi: 10.1002/prca.200780088. Epub 2008 Mar 7. PMID: 21136859.
  41. Bones J, Byrne JC, O'Donoghue N, McManus C, Scaife C, Boissin H, Nastase A, Rudd PM. Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms. J Proteome Res. 2011 Mar 4;10(3):1246-65. doi: 10.1021/pr101036b. Epub 2011 Jan 19. PMID: 21142185.
  42. Bai Z, Ye Y, Liang B, Xu F, Zhang H, Zhang Y, Peng J, Shen D, Cui Z, Zhang Z, Wang S. Proteomics-based identification of a group of apoptosis-related proteins and biomarkers in gastric cancer. Int J Oncol. 2011 Feb;38(2):375-83. doi: 10.3892/ijo.2010.873. Epub 2010 Dec 15. PMID: 21165559.
  43. Cohen M, Yossef R, Erez T, Kugel A, Welt M, Karpasas MM, Bones J, Rudd PM, Taieb J, Boissin H, Harats D, Noy K, Tekoah Y, Lichtenstein RG, Rubin E, Porgador A. Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays. PLoS One. 2011 Jan 18;6(1):e14540. doi: 10.1371/journal.pone.0014540. PMID: 21267442; PMCID: PMC3022591.
  44. Umemura H, Togawa A, Sogawa K, Satoh M, Mogushi K, Nishimura M, Matsushita K, Tanaka H, Takizawa H, Kodera Y, Nomura F. Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis. J Gastroenterol. 2011 May;46(5):577-85. doi: 10.1007/s00535-010-0369-3. Epub 2011 Feb 5. PMID: 21298293.
  45. Xia YJ, Ma YY, He XJ, Wang HJ, Ye ZY, Tao HQ. Suppression of selenium- binding protein 1 in gastric cancer is associated with poor survival. Hum Pathol. 2011 Nov;42(11):1620-8. doi: 10.1016/j.humpath.2011.01.008. Epub 2011 Apr 15. PMID: 21497372.
  46. Balluff B, Rauser S, Meding S, Elsner M, Schöne C, Feuchtinger A, Schuhmacher C, Novotny A, Jütting U, Maccarrone G, Sarioglu H, Ueffing M, Braselmann H, Zitzelsberger H, Schmid RM, Höfler H, Ebert MP, Walch A. MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer. Am J Pathol. 2011 Dec;179(6):2720-9. doi: 10.1016/j.ajpath.2011.08.032. Epub 2011 Oct 18. PMID: 22015459; PMCID: PMC3260837.
  47. Jung JH, Kim HJ, Yeom J, Yoo C, Shin J, Yoo J, Kang CS, Lee C. Lowered expression of galectin-2 is associated with lymph node metastasis in gastric cancer. J Gastroenterol. 2012 Jan;47(1):37-48. doi: 10.1007/s00535-011-0463-1. Epub 2011 Oct 21. PMID: 22015694.
  48. Liu W, Liu B, Cai Q, Li J, Chen X, Zhu Z. Proteomic identification of serum biomarkers for gastric cancer using multi-dimensional liquid chromatography and 2D differential gel electrophoresis. Clin Chim Acta. 2012 Jul 11;413(13-14):1098-106. doi: 10.1016/j.cca.2012.03.003. Epub 2012 Mar 13. PMID: 22446497.
  49. Kočevar N, Odreman F, Vindigni A, Grazio SF, Komel R. Proteomic analysis of gastric cancer and immunoblot validation of potential biomarkers. World J Gastroenterol. 2012 Mar 21;18(11):1216-28. doi: 10.3748/wjg.v18.i11.1216. PMID: 22468085; PMCID: PMC3309911.
  50. Wu W, Juan WC, Liang CR, Yeoh KG, So J, Chung MC. S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis. Proteomics Clin Appl. 2012 Apr;6(3-4):152-62. doi: 10.1002/prca.201100050. PMID: 22532451.
  51. Tanca A, Addis MF, Simula MP, Pagnozzi D, Biosa G, Pisanu S, Garziera M, Cannizzaro R, Canzonieri V, De Re V, Uzzau S. Evaluation of the suitability of archival Bouin-fixed paraffin-embedded tissue specimens to proteomic investigation. Electrophoresis. 2012 May;33(9-10):1375-84. doi: 10.1002/elps.201200026. PMID: 22648804.
  52. Cheng CC, Lu N, Peng CL, Chang CC, Mai FD, Chen LY, Liao MH, Wang WM, Chang J. Targeting to overexpressed glucose-regulated protein 78 in gastric cancer discovered by 2D DIGE improves the diagnostic and therapeutic efficacy of micelles-mediated system. Proteomics. 2012 Aug;12(15-16):2584-97. doi: 10.1002/pmic.201100602. PMID: 22778057.
  53. Leal MF, Chung J, Calcagno DQ, Assumpção PP, Demachki S, da Silva ID, Chammas R, Burbano RR, de Arruda Cardoso Smith M. Differential proteomic analysis of noncardia gastric cancer from individuals of northern Brazil. PLoS One. 2012;7(7):e42255. doi: 10.1371/journal.pone.0042255. Epub 2012 Jul 30. PMID: 22860099; PMCID: PMC3408468.
  54. Sousa JF, Ham AJ, Whitwell C, Nam KT, Lee HJ, Yang HK, Kim WH, Zhang B, Li M, LaFleur B, Liebler DC, Goldenring JR. Proteomic profiling of paraffin- embedded samples identifies metaplasia-specific and early-stage gastric cancer biomarkers. Am J Pathol. 2012 Nov;181(5):1560-72. doi: 10.1016/j.ajpath.2012.07.027. Epub 2012 Sep 1. PMID: 22944598; PMCID: PMC3483808.
  55. Liu C, Pan C, Liang Y. Screening and identification of serum proteomic biomarkers for gastric adenocarcinoma. Exp Ther Med. 2012 Jun;3(6):1005-1009. doi: 10.3892/etm.2012.515. Epub 2012 Mar 14. PMID: 22970007; PMCID: PMC3438544.
  56. Choi JH, Shin NR, Moon HJ, Kwon CH, Kim GH, Song GA, Jeon TY, Kim DH, Kim DH, Park DY. Identification of S100A8 and S100A9 as negative regulators for lymph node metastasis of gastric adenocarcinoma. Histol Histopathol. 2012 Nov;27(11):1439-48. doi: 10.14670/HH-27.1439. PMID: 23018243.
  57. Singhal R, Carrigan JB, Wei W, Taniere P, Hejmadi RK, Forde C, Ludwig C, Bunch J, Griffiths RL, Johnson PJ, Tucker O, Alderson D, Günther UL, Ward DG. MALDI profiles of proteins and lipids for the rapid characterisation of upper GI-tract cancers. J Proteomics. 2013 Mar 27;80:207-15. doi: 10.1016/j.jprot.2013.01.016. Epub 2013 Feb 1. PMID: 23376328.
  58. Zhang MH, Xu XH, Wang Y, Linq QX, Bi YT, Miao XJ, Ye CF, Gao SX, Gong CY, Xiang H, Dong MS. A prognostic biomarker for gastric cancer with lymph node metastases. Anat Rec (Hoboken). 2013 Apr;296(4):590-4. doi: 10.1002/ar.22642. Epub 2013 Feb 4. PMID: 23382154.
  59. Uen YH, Lin KY, Sun DP, Liao CC, Hsieh MS, Huang YK, Chen YW, Huang PH, Chen WJ, Tai CC, Lee KW, Chen YC, Lin CY. Comparative proteomics, network analysis and post-translational modification identification reveal differential profiles of plasma Con A-bound glycoprotein biomarkers in gastric cancer. J Proteomics. 2013 May 27;83:197-213. doi: 10.1016/j.jprot.2013.03.007. Epub 2013 Mar 26. PMID: 23541716.
  60. Fan NJ, Li K, Liu QY, Wang XL, Hu L, Li JT, Gao CF. Identification of tubulin beta chain, thymosin beta-4-like protein 3, and cytochrome b-c₁ complex subunit 1 as serological diagnostic biomarkers of gastric cancer. Clin Biochem. 2013 Oct;46(15):1578-84. doi: 10.1016/j.clinbiochem.2013.05.068. Epub 2013 Jun 6. PMID: 23747515.
  61. Zhang ZQ, Li XJ, Liu GT, Xia Y, Zhang XY, Wen H. Identification of Annexin A1 protein expression in human gastric adenocarcinoma using proteomics and tissue microarray. World J Gastroenterol. 2013 Nov 21;19(43):7795-803. doi: 10.3748/wjg.v19.i43.7795. PMID: 24282368; PMCID: PMC3837281.
  62. Aquino PF, Lima DB, de Saldanha da Gama Fischer J, Melani RD, Nogueira FC, Chalub SR, Soares ER, Barbosa VC, Domont GB, Carvalho PC. Exploring the proteomic landscape of a gastric cancer biopsy with the shotgun imaging analyzer. J Proteome Res. 2014 Jan 3;13(1):314-20. doi: 10.1021/pr400919k. Epub 2013 Nov 27. PMID: 24283986.
  63. Kočevar N, Grazio SF, Komel R. Two-dimensional gel electrophoresis of gastric tissue in an alkaline pH range. Proteomics. 2014 Feb;14(2-3):311-21. doi: 10.1002/pmic.201200574. Epub 2014 Jan 6. PMID: 24293252.
  64. Wang Y, Song G, Wang Y, Qiu L, Qin X, Liu H, Li F, Wang X, Li F, Guo S, Zhang Y, Li Z. Elevated serum levels of circulating immunoinflammation-related protein complexes are associated with cancer. J Proteome Res. 2014 Feb 7;13(2):710-9. doi: 10.1021/pr4008255. Epub 2013 Dec 17. PMID: 24295561.
  65. Liu YF, Liu QQ, Wang X, Luo CH. Clinical significance of S100A2 expression in gastric cancer. Tumour Biol. 2014 Apr;35(4):3731-41. doi: 10.1007/s13277-013-1495-3. Epub 2013 Dec 7. PMID: 24318973.
  66. Wu JY, Cheng CC, Wang JY, Wu DC, Hsieh JS, Lee SC, Wang WM. Discovery of tumor markers for gastric cancer by proteomics. PLoS One. 2014 Jan 3;9(1):e84158. doi: 10.1371/journal.pone.0084158. PMID: 24404153; PMCID: PMC3880290.
  67. Humphries JM, Penno MA, Weiland F, Klingler-Hoffmann M, Zuber A, Boussioutas A, Ernst M, Hoffmann P. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer. Biochim Biophys Acta. 2014 May;1844(5):1051-8. doi: 10.1016/j.bbapap.2014.01.018. Epub 2014 Feb 7. PMID: 24512919.
  68. Ichikawa H, Yoshida A, Kanda T, Kosugi S, Ishikawa T, Hanyu T, Taguchi T, Sakumoto M, Katai H, Kawai A, Wakai T, Kondo T. Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis. Cancer Sci. 2015 Jan;106(1):115-24. doi: 10.1111/cas.12565. Epub 2014 Dec 4. PMID: 25457157; PMCID: PMC4317774.
  69. Yang J, Xiong X, Wang X, Guo B, He K, Huang C. Identification of peptide regions of SERPINA1 and ENOSF1 and their protein expression as potential serum biomarkers for gastric cancer. Tumour Biol. 2015 Jul;36(7):5109-18. doi: 10.1007/s13277-015-3163-2. Epub 2015 Feb 14. PMID: 25677901.
  70. Subbannayya Y, Syed N, Barbhuiya MA, Raja R, Marimuthu A, Sahasrabuddhe N, Pinto SM, Manda SS, Renuse S, Manju HC, Zameer MA, Sharma J, Brait M, Srikumar K, Roa JC, Vijaya Kumar M, Kumar KV, Prasad TS, Ramaswamy G, Kumar RV, Pandey A, Gowda H, Chatterjee A. Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma. Cancer Biol Ther. 2015;16(2):336-45. doi: 10.4161/15384047.2014.972264. PMID: 25756516; PMCID: PMC4622549.
  71. Gao W, Xu J, Wang F, Zhang L, Peng R, Shu Y, Wu J, Tang Q, Zhu Y. Plasma membrane proteomic analysis of human Gastric Cancer tissues: revealing flotillin 1 as a marker for Gastric Cancer. BMC Cancer. 2015 May 7;15:367. doi: 10.1186/s12885-015-1343-5. PMID: 25948494; PMCID: PMC4525731.
  72. Subbannayya Y, Mir SA, Renuse S, Manda SS, Pinto SM, Puttamallesh VN, Solanki HS, Manju HC, Syed N, Sharma R, Christopher R, Vijayakumar M, Veerendra Kumar KV, Keshava Prasad TS, Ramaswamy G, Kumar RV, Chatterjee A, Pandey A, Gowda H. Identification of differentially expressed serum proteins in gastric adenocarcinoma. J Proteomics. 2015 Sep 8;127(Pt A):80-8. doi: 10.1016/j.jprot.2015.04.021. Epub 2015 May 5. PMID: 25952687; PMCID: PMC4618463.
  73. Abramowicz A, Wojakowska A, Gdowicz-Klosok A, Polanska J, Rodziewicz P, Polanowski P, Namysl-Kaletka A, Pietrowska M, Wydmanski J, Widlak P. Identification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot study. J Transl Med. 2015 Sep 17;13:304. doi: 10.1186/s12967-015-0668-9. PMID: 26376850; PMCID: PMC4574216.
  74. Ran X, Xu X, Yang Y, She S, Yang M, Li S, Peng H, Ding X, Hu H, Hu P, Zhang D, Ren H, Wu L, Zeng W. A quantitative proteomics study on olfactomedin 4 in the development of gastric cancer. Int J Oncol. 2015 Nov;47(5):1932-44. doi: 10.3892/ijo.2015.3168. Epub 2015 Sep 16. PMID: 26398045.
  75. Gao W, Xua J, Wang F, Zhang L, Peng R, Zhu Y, Tang Q, Wu J. Mitochondrial Proteomics Approach Reveals Voltage-Dependent Anion Channel 1 (VDAC1) as a Potential Biomarker of Gastric Cancer. Cell Physiol Biochem. 2015;37(6):2339-54. doi: 10.1159/000438588. Epub 2015 Dec 7. PMID: 26646027.
  76. Park JM, Park JH, Mun DG, Bae J, Jung JH, Back S, Lee H, Kim H, Jung HJ, Kim HK, Lee H, Kim KP, Hwang D, Lee SW. Integrated analysis of global proteome, phosphoproteome, and glycoproteome enables complementary interpretation of disease-related protein networks. Sci Rep. 2015 Dec 11;5:18189. doi: 10.1038/srep18189. PMID: 26657352; PMCID: PMC4676070.
  77. Wu C, Luo Z, Tang D, Liu L, Yao D, Zhu L, Wang Z. Identification of carboxyl terminal peptide of Fibrinogen as a potential serum biomarker for gastric cancer. Tumour Biol. 2016 May;37(5):6963-70. doi: 10.1007/s13277-015-4394-y. Epub 2015 Dec 11. PMID: 26662807.
  78. Xiao H, Zhang Y, Kim Y, Kim S, Kim JJ, Kim KM, Yoshizawa J, Fan LY, Cao CX, Wong DT. Differential Proteomic Analysis of Human Saliva using Tandem Mass Tags Quantification for Gastric Cancer Detection. Sci Rep. 2016 Feb 25;6:22165. doi: 10.1038/srep22165. PMID: 26911362; PMCID: PMC4766442.
  79. Song D, Yue L, Li H, Zhang J, Yan Z, Fan Y, Yang H, Liu Q, Zhang D, Xia Z, Qin P, Jia J, Yue M, Yu J, Zheng S, Yang F, Wang J. Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometry. Br J Cancer. 2016 Apr 12;114(8):929-38. doi: 10.1038/bjc.2016.52. Epub 2016 Mar 22. PMID: 27002935; PMCID: PMC4984799.
  80. Wu W, Yong WW, Chung MC. A simple biomarker scoring matrix for early gastric cancer detection. Proteomics. 2016 Nov;16(22):2921-2930. doi: 10.1002/pmic.201600194. Epub 2016 Sep 6. PMID: 27488579.
  81. Zhou X, Yao K, Zhang L, Zhang Y, Han Y, Liu HL, Liu XW, Su G, Yuan WZ, Wei XD, Guan QL, Zhu BD. Identification of Differentiation-Related Proteins in Gastric Adenocarcinoma Tissues by Proteomics. Technol Cancer Res Treat. 2016 Oct;15(5):697-706. doi: 10.1177/1533034615595792. PMID: 27624754.
  82. An E, Ock CY, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Liao WL, Cecchi F, Blackler A, Thyparambil S, Kim WH, Burrows J, Hembrough T, Catenacci DVT, Oh DY, Bang YJ. Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment. Ann Oncol. 2017 Jan 1;28(1):110-115. doi: 10.1093/annonc/mdw442. PMID: 27687309; PMCID: PMC5378223.
  83. Catenacci DV, Ang A, Liao WL, Shen J, O'Day E, Loberg RD, Cecchi F, Hembrough T, Ruzzo A, Graziano F. MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma. Cancer. 2017 May 15;123(6):1061-1070. doi: 10.1002/cncr.30437. Epub 2016 Dec 7. PMID: 27926778; PMCID: PMC5339041.
  84. Wang X, Zhi Q, Liu S, Xue SL, Shen C, Li Y, Wu C, Tang Z, Chen W, Song JL, Bao M, Song YH, Zhou J. Identification of specific biomarkers for gastric adenocarcinoma by ITRAQ proteomic approach. Sci Rep. 2016 Dec 12;6:38871. doi: 10.1038/srep38871. PMID: 27941907; PMCID: PMC5150883.
  85. Yoo MW, Park J, Han HS, Yun YM, Kang JW, Choi DY, Lee JW, Jung JH, Lee KY, Kim KP. Discovery of gastric cancer specific biomarkers by the application of serum proteomics. Proteomics. 2017 Mar;17(6). doi: 10.1002/pmic.201600332. PMID: 28133907.
  86. Song Y, Wang J, Cheng Z, Gao P, Sun J, Chen X, Chen C, Wang Y, Wang Z. Quantitative global proteome and lysine succinylome analyses provide insights into metabolic regulation and lymph node metastasis in gastric cancer. Sci Rep. 2017 Feb 6;7:42053. doi: 10.1038/srep42053. PMID: 28165029; PMCID: PMC5292683.
  87. Jiang Z, Shen H, Tang B, Chen H, Yu Q, Ji X, Wang L. Identification of diagnostic markers involved in the pathogenesis of gastric cancer through iTRAQ- based quantitative proteomics. Data Brief. 2017 Jan 18;11:122-126. doi: 10.1016/j.dib.2016.12.023. PMID: 28180141; PMCID: PMC5288326.
  88. Liu F, Zhang Y, Men T, Jiang X, Yang C, Li H, Wei X, Yan D, Feng G, Yang J, Bergquist J, Wang B, Jiang W, Mi J, Tian G. Quantitative proteomic analysis of gastric cancer tissue reveals novel proteins in platelet-derived growth factor b signaling pathway. Oncotarget. 2017 Mar 28;8(13):22059-22075. doi: 10.18632/oncotarget.15908. PMID: 28423550; PMCID: PMC5400646.
  89. Liu XX, Ye H, Wang P, Zhang Y, Zhang JY. Identification of 14‑3‑3ζ as a potential biomarker in gastric cancer by proteomics‑based analysis. Mol Med Rep. 2017 Nov;16(5):7759-7765. doi: 10.3892/mmr.2017.7496. Epub 2017 Sep 18. PMID: 28944820.
  90. Wang FR, Wei YC, Han ZJ, He WT, Guan XY, Chen H, Li YM. Aberrant DNA-PKcs and ERGIC1 expression may be involved in initiation of gastric cancer. World J Gastroenterol. 2017 Sep 7;23(33):6119-6127. doi: 10.3748/wjg.v23.i33.6119. PMID: 28970727; PMCID: PMC5597503.
  91. Wippel HH, Santos MDM, Clasen MA, Kurt LU, Nogueira FCS, Carvalho CE, McCormick TM, Neto GPB, Alves LR, da Gloria da Costa Carvalho M, Carvalho PC, Fischer JSDG. Comparing intestinal versus diffuse gastric cancer using a PEFF- oriented proteomic pipeline. J Proteomics. 2018 Jan 16;171:63-72. doi: 10.1016/j.jprot.2017.10.005. Epub 2017 Oct 12. PMID: 29032071.
  92. Cheng CW, Chang CC, Patria YN, Chang RT, Liu YR, Li FA, Shih HM, Lin CY. Sex hormone-binding globulin (SHBG) is a potential early diagnostic biomarker for gastric cancer. Cancer Med. 2018 Jan;7(1):64-74. doi: 10.1002/cam4.1254. Epub 2017 Nov 17. PMID: 29148252; PMCID: PMC5773940.
  93. Tsai CY, Chi HC, Chi LM, Yang HY, Tsai MM, Lee KF, Huang HW, Chou LF, Cheng AJ, Yang CW, Wang CS, Lin KH. Argininosuccinate synthetase 1 contributes to gastric cancer invasion and progression by modulating autophagy. FASEB J. 2018 May;32(5):2601-2614. doi: 10.1096/fj.201700094R. Epub 2018 Jan 10. Erratum in: FASEB J. 2019 Jan;33(1):1522. PMID: 29401583.
  94. Ge S, Xia X, Ding C, Zhen B, Zhou Q, Feng J, Yuan J, Chen R, Li Y, Ge Z, Ji J, Zhang L, Wang J, Li Z, Lai Y, Hu Y, Li Y, Li Y, Gao J, Chen L, Xu J, Zhang C, Jung SY, Choi JM, Jain A, Liu M, Song L, Liu W, Guo G, Gong T, Huang Y, Qiu Y, Huang W, Shi T, Zhu W, Wang Y, He F, Shen L, Qin J. A proteomic landscape of diffuse-type gastric cancer. Nat Commun. 2018 Mar 8;9(1):1012. doi: 10.1038/s41467-018-03121-2. Erratum in: Nat Commun. 2018 May 8;9(1):1850. PMID: 29520031; PMCID: PMC5843664.
  95. Jin J, Son M, Kim H, Kim H, Kong SH, Kim HK, Kim Y, Han D. Comparative proteomic analysis of human malignant ascitic fluids for the development of gastric cancer biomarkers. Clin Biochem. 2018 Jun;56:55-61. doi: 10.1016/j.clinbiochem.2018.04.003. Epub 2018 Apr 11. PMID: 29654727.
  96. Shi F, Wu H, Qu K, Sun Q, Li F, Shi C, Li Y, Xiong X, Qin Q, Yu T, Jin X, Cheng L, Wei Q, Li Y, She J. Identification of serum proteins AHSG, FGA and APOA-I as diagnostic biomarkers for gastric cancer. Clin Proteomics. 2018 Apr 30;15:18. doi: 10.1186/s12014-018-9194-0. PMID: 29719494; PMCID: PMC5925839.
  97. Fu H, Yang H, Zhang X, Wang B, Mao J, Li X, Wang M, Zhang B, Sun Z, Qian H, Xu W. Exosomal TRIM3 is a novel marker and therapy target for gastric cancer. J Exp Clin Cancer Res. 2018 Jul 21;37(1):162. doi: 10.1186/s13046-018-0825-0. PMID: 30031392; PMCID: PMC6054744.
  98. Fernández-Coto DL, Gil J, Hernández A, Herrera-Goepfert R, Castro-Romero I, Hernández-Márquez E, Arenas-Linares AS, Calderon-Sosa VT, Sanchez-Aleman MÁ, Mendez-Tenorio A, Encarnación-Guevara S, Ayala G. Quantitative proteomics reveals proteins involved in the progression from non-cancerous lesions to gastric cancer. J Proteomics. 2018 Aug 30;186:15-27. doi: 10.1016/j.jprot.2018.07.013. Epub 2018 Jul 23. PMID: 30048774.
  99. Ahn HS, Sohn TS, Kim MJ, Cho BK, Kim SM, Kim ST, Yi EC, Lee C. SEPROGADIC - serum protein-based gastric cancer prediction model for prognosis and selection of proper adjuvant therapy. Sci Rep. 2018 Nov 15;8(1):16892. doi: 10.1038/s41598-018-34858-x. PMID: 30442939; PMCID: PMC6237900.
  100. Jiang Z, Zhang C, Gan L, Jia Y, Xiong Y, Chen Y, Wang Z, Wang L, Luo H, Li J, Zhu R, Ji X, Yu Q, Wang L. iTRAQ-Based Quantitative Proteomics Approach Identifies Novel Diagnostic Biomarkers That Were Essential for Glutamine Metabolism and Redox Homeostasis for Gastric Cancer. Proteomics Clin Appl. 2019 Jul;13(4):e1800038. doi: 10.1002/prca.201800038. Epub 2019 Jan 4. PMID: 30485682.
  101. Zhou B, Zhou Z, Chen Y, Deng H, Cai Y, Rao X, Yin Y, Rong L. Plasma proteomics-based identification of novel biomarkers in early gastric cancer. Clin Biochem. 2020 Feb;76:5-10. doi: 10.1016/j.clinbiochem.2019.11.001. Epub 2019 Nov 22. PMID: 31765635.
  102. Abe Y, Hirano H, Shoji H, Tada A, Isoyama J, Kakudo A, Gunji D, Honda K, Boku N, Adachi J, Tomonaga T. Comprehensive characterization of the phosphoproteome of gastric cancer from endoscopic biopsy specimens. Theranostics. 2020 Jan 12;10(5):2115-2129. doi: 10.7150/thno.37623. PMID: 32089736; PMCID: PMC7019165.
  103. de Oliveira TM, de Lacerda JTJG, Leite GGF, Dias M, Mendes MA, Kassab P, E Silva CGS, Juliano MA, Forones NM. Label-free peptide quantification coupled with in silico mapping of proteases for identification of potential serum biomarkers in gastric adenocarcinoma patients. Clin Biochem. 2020 May;79:61-69. doi: 10.1016/j.clinbiochem.2020.02.010. Epub 2020 Feb 22. PMID: 32097616.
  104. Min L, Zhu S, Wei R, Zhao Y, Liu S, Li P, Zhang S. Integrating SWATH-MS Proteomics and Transcriptome Analysis Identifies CHI3L1 as a Plasma Biomarker for Early Gastric Cancer. Mol Ther Oncolytics. 2020 Apr 7;17:257-266. doi: 10.1016/j.omto.2020.03.020. PMID: 32346614; PMCID: PMC7186562.
  105. Shen J, Zhai J, Wu X, Xie G, Shen L. Serum proteome profiling reveals SOX3 as a candidate prognostic marker for gastric cancer. J Cell Mol Med. 2020 Jun;24(12):6750-6761. doi: 10.1111/jcmm.15326. Epub 2020 May 4. PMID: 32363730; PMCID: PMC7299728.
  106. Ding XQ, Wang ZY, Xia D, Wang RX, Pan XR, Tong JH. Proteomic Profiling of Serum Exosomes From Patients With Metastatic Gastric Cancer. Front Oncol. 2020 Jul 10;10:1113. doi: 10.3389/fonc.2020.01113. PMID: 32754443; PMCID: PMC7367030.
  107. Su F, Zhou FF, Zhang T, Wang DW, Zhao D, Hou XM, Feng MH. Quantitative proteomics identified 3 oxidative phosphorylation genes with clinical prognostic significance in gastric cancer. J Cell Mol Med. 2020 Sep;24(18):10842-10854. doi: 10.1111/jcmm.15712. Epub 2020 Aug 5. PMID: 32757436; PMCID: PMC7521272.
  108. Li X, Zhang C, Zhao T, Su Z, Li M, Hu J, Wen J, Shen J, Wang C, Pan J, Mu X, Ling T, Li Y, Wen H, Zhang X, You Q. Lysine-222 succinylation reduces lysosomal degradation of lactate dehydrogenase a and is increased in gastric cancer. J Exp Clin Cancer Res. 2020 Aug 28;39(1):172. doi: 10.1186/s13046-020-01681-0. PMID: 32859246; PMCID: PMC7455916.
  109. Shimura T, Dayde D, Wang H, Okuda Y, Iwasaki H, Ebi M, Kitagawa M, Yamada T, Yamada T, Hanash SM, Taguchi A, Kataoka H. Novel urinary protein biomarker panel for early diagnosis of gastric cancer. Br J Cancer. 2020 Nov;123(11):1656-1664. doi: 10.1038/s41416-020-01063-5. Epub 2020 Sep 16. PMID: 32934343; PMCID: PMC7686371.
  110. Zhou Y, Lih TM, Pan J, Höti N, Dong M, Cao L, Hu Y, Cho KC, Chen SY, Eguez RV, Gabrielson E, Chan DW, Zhang H, Li QK. Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets. J Hematol Oncol. 2020 Dec 7;13(1):170. doi: 10.1186/s13045-020-01013-x. PMID: 33287876; PMCID: PMC7720039.
  111. Yang Z, Yan C, Yu Z, He C, Li J, Li C, Yan M, Liu B, Wu Y, Zhu Z. Downregulation of CDH11 Promotes Metastasis and Resistance to Paclitaxel in Gastric Cancer Cells. J Cancer. 2021 Jan 1;12(1):65-75. doi: 10.7150/jca.48193. PMID: 33391403; PMCID: PMC7738820.
  112. Osório H, Silva C, Ferreira M, Gullo I, Máximo V, Barros R, Mendonça F, Oliveira C, Carneiro F. Proteomics Analysis of Gastric Cancer Patients with Diabetes Mellitus. J Clin Med. 2021 Jan 21;10(3):407. doi: 10.3390/jcm10030407. PMID: 33494396; PMCID: PMC7866049.
  113. Song Y, Wang J, Sun J, Chen X, Shi J, Wu Z, Yu D, Zhang F, Wang Z. Screening of Potential Biomarkers for Gastric Cancer with Diagnostic Value Using Label-free Global Proteome Analysis. Genomics Proteomics Bioinformatics. 2020 Dec;18(6):679-695. doi: 10.1016/j.gpb.2020.06.012. Epub 2021 Feb 17. PMID: 33607292; PMCID: PMC8377014.
  114. Fan Y, Bai B, Liang Y, Ren Y, Liu Y, Zhou F, Lou X, Zi J, Hou G, Chen F, Zhao Q, Liu S. Proteomic Profiling of Gastric Signet Ring Cell Carcinoma Tissues Reveals Characteristic Changes of the Complement Cascade Pathway. Mol Cell Proteomics. 2021;20:100068. doi: 10.1016/j.mcpro.2021.100068. Epub 2021 Mar 3. PMID: 33676000; PMCID: PMC8121970.
  115. Ye D, Li Y, Zhang H, Zhou Z, Tang Y, Wu P, Zhao Q, Zhang Z. Silencing PRSS1 suppresses the growth and proliferation of gastric carcinoma cells via the ERK pathway. Int J Biol Sci. 2021 Mar 1;17(4):957-971. doi: 10.7150/ijbs.52591. PMID: 33867821; PMCID: PMC8040304.
  116. Yang Z, Yan C, Liu W, Xu W, Li C, Yan M, Liu B, Zhu Z. Identification of novel autoantibodies in ascites of relapsed paclitaxel-resistant gastric cancer with peritoneal metastasis using immunome protein microarrays and proteomics. Cancer Biomark. 2021;31(4):329-338. doi: 10.3233/CBM-203142. PMID: 33896831.
  117. Li Y, Wang P, Ye D, Bai X, Zeng X, Zhao Q, Zhang Z. IGHG1 induces EMT in gastric cancer cells by regulating TGF-β/SMAD3 signaling pathway. J Cancer. 2021 Apr 19;12(12):3458-3467. doi: 10.7150/jca.56056. PMID: 33995624; PMCID: PMC8120194.
  118. Sivagnanam A, Thangasamy B, Nagarajan V, Ravi SG, Madhesh JC, Perumal MA, Karunakaran P, Jayaraman M. Comparative Proteomic Analysis Reveals Novel Biomarkers for Gastric Cancer in South Indian Tamil Population. Comb Chem High Throughput Screen. 2022;25(8):1361-1373. doi: 10.2174/1386207324666210603120320. PMID: 34082671.
  119. Wang Z, Lv Z, Xu Q, Sun L, Yuan Y. Identification of differential proteomics in Epstein-Barr virus-associated gastric cancer and related functional analysis. Cancer Cell Int. 2021 Jul 12;21(1):368. doi: 10.1186/s12935-021-02077-6. PMID: 34247602; PMCID: PMC8274036.
  120. Huang W, Zhan D, Li Y, Zheng N, Wei X, Bai B, Zhang K, Liu M, Zhao X, Ni X, Xia X, Shi J, Zhang C, Lu Z, Ji J, Wang J, Wang S, Ji G, Li J, Nie Y, Liang W, Wu X, Cui J, Meng Y, Cao F, Shi T, Zhu W, Wang Y, Chen L, Zhao Q, Wang H, Shen L, Qin J. Proteomics provides individualized options of precision medicine for patients with gastric cancer. Sci China Life Sci. 2021 Aug;64(8):1199-1211. doi: 10.1007/s11427-021-1966-4. Epub 2021 Jul 9. PMID: 34258712.
  121. Santos EC, Binato R, Fernandes PV, Ferreira MA, Abdelhay E. The protein- protein interaction network of intestinal gastric cancer patients reveals hub proteins with potential prognostic value. Cancer Biomark. 2022;33(1):83-96. doi: 10.3233/CBM-203225. PMID: 34366321.
  122. Liu J, Li J, Sun Z, Duan Y, Wang F, Wei G, Yang JH. Bcl-2-associated transcription factor 1 Ser290 phosphorylation mediates DNA damage response and regulates radiosensitivity in gastric cancer. J Transl Med. 2021 Aug 9;19(1):339. doi: 10.1186/s12967-021-03004-z. PMID: 34372878; PMCID: PMC8351323.
  123. Li X, Zheng NR, Wang LH, Li ZW, Liu ZC, Fan H, Wang Y, Dai J, Ni XT, Wei X, Liu MW, Li K, Li ZX, Zhou T, Zhang Y, Zhang JY, Kadeerhan G, Huang S, Wu WH, Liu WD, Wu XZ, Zhang LF, Xu JM, Gerhard M, You WC, Pan KF, Li WQ, Qin J. Proteomic profiling identifies signatures associated with progression of precancerous gastric lesions and risk of early gastric cancer. EBioMedicine. 2021 Dec;74:103714. doi: 10.1016/j.ebiom.2021.103714. Epub 2021 Nov 22. PMID: 34818622; PMCID: PMC8617343.
  124. Singh S, Bhat MY, Sathe G, Gopal C, Sharma J, Madugundu AK, Joshi NS, Pandey A. Proteomic Signatures of Diffuse and Intestinal Subtypes of Gastric Cancer. Cancers (Basel). 2021 Nov 25;13(23):5930. doi: 10.3390/cancers13235930. PMID: 34885041; PMCID: PMC8656738.
  125. Zhang Y, Liu W, Feng W, Wang X, Lei T, Chen Z, Song W. Identification of 14 Differentially-Expressed Metabolism-Related Genes as Potential Targets of Gastric Cancer by Integrated Proteomics and Transcriptomics. Front Cell Dev Biol. 2022 Feb 21;10:816249. doi: 10.3389/fcell.2022.816249. PMID: 35265615; PMCID: PMC8899292.
  126. Hirano H, Abe Y, Nojima Y, Aoki M, Shoji H, Isoyama J, Honda K, Boku N, Mizuguchi K, Tomonaga T, Adachi J. Temporal dynamics from phosphoproteomics using endoscopic biopsy specimens provides new therapeutic targets in stage IV gastric cancer. Sci Rep. 2022 Mar 25;12(1):4419. doi: 10.1038/s41598-022-08430-7. PMID: 35338158; PMCID: PMC8956597.
  127. Moreira AM, Ferreira RM, Carneiro P, Figueiredo J, Osório H, Barbosa J, Preto J, Pinto-do-Ó P, Carneiro F, Seruca R. Proteomic Identification of a Gastric Tumor ECM Signature Associated With Cancer Progression. Front Mol Biosci. 2022 Mar 1;9:818552. doi: 10.3389/fmolb.2022.818552. PMID: 35340765; PMCID: PMC8942767.
  128. Li X, Pan K, Vieth M, Gerhard M, Li W, Mejías-Luque R. JAK-STAT1 Signaling Pathway Is an Early Response to Helicobacter pylori Infection and Contributes to Immune Escape and Gastric Carcinogenesis. Int J Mol Sci. 2022 Apr 8;23(8):4147. doi: 10.3390/ijms23084147. PMID: 35456965; PMCID: PMC9031264.
  129. Li H, Fu X, Zhao J, Li C, Li L, Xia P, Guo J, Wei W, Zeng R, Wu J, Sun Y, Huang L, Wang X. EXOC4 Promotes Diffuse-Type Gastric Cancer Metastasis via Activating FAK Signal. Mol Cancer Res. 2022 Jul 6;20(7):1021-1034. doi: 10.1158/1541-7786.MCR-21-0441. PMID: 35471457; PMCID: PMC9381130.
  130. Aziz S, Rasheed F, Zahra R, König S. Gastric Cancer Pre-Stage Detection and Early Diagnosis of Gastritis Using Serum Protein Signatures. Molecules. 2022 Apr 30;27(9):2857. doi: 10.3390/molecules27092857. PMID: 35566209; PMCID: PMC9099457.
  131. Chu PY, Huang WC, Tung SL, Tsai CY, Chen CJ, Liu YC, Lee CW, Lin YH, Lin HY, Chen CY, Yeh CT, Lin KH, Chi HC. IFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET/AKT/FOXO3/c-MYC axis. Cell Biosci. 2022 Aug 8;12(1):124. doi: 10.1186/s13578-022-00858-8. PMID: 35941699; PMCID: PMC9361616.
  132. Dhondrup R, Zhang X, Feng X, Lobsang D, Hua Q, Liu J, Cuo Y, Zhuoma S, Duojie G, Duojie Caidan S, Gyal S. Proteomic Analysis Reveals Molecular Differences in the Development of Gastric Cancer. Evid Based Complement Alternat Med. 2022 Jul 31;2022:8266544. doi: 10.1155/2022/8266544. PMID: 35958927; PMCID: PMC9357686.
  133. Li Y, Xu C, Wang B, Xu F, Ma F, Qu Y, Jiang D, Li K, Feng J, Tian S, Wu X, Wang Y, Liu Y, Qin Z, Liu Y, Qin J, Song Q, Zhang X, Sujie A, Huang J, Liu T, Shen K, Zhao JY, Hou Y, Ding C. Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals new therapeutic strategies. Nat Commun. 2022 Sep 29;13(1):5723. doi: 10.1038/s41467-022-33282-0. Erratum in: Nat Commun. 2022 Nov 8;13(1):6749. PMID: 36175412; PMCID: PMC9522856.
  134. Tang X, Liang Y, Sun G, He Q, Hou Z, Jiang X, Gao P, Qu H. Upregulation of CRABP2 by TET1-mediated DNA hydroxymethylation attenuates mitochondrial apoptosis and promotes oxaliplatin resistance in gastric cancer. Cell Death Dis. 2022 Oct 4;13(10):848. doi: 10.1038/s41419-022-05299-2. PMID: 36195596; PMCID: PMC9532395.
  135. Fan H, Li X, Li ZW, Zheng NR, Cao LH, Liu ZC, Liu MW, Li K, Wu WH, Li ZX, Zhou T, Zhang Y, Liu WD, Zhang LF, You WC, Wang Y, Wu J, Pan KF, Qin J, Li WQ. Urine proteomic signatures predicting the progression from premalignancy to malignant gastric cancer. EBioMedicine. 2022 Dec;86:104340. doi: 10.1016/j.ebiom.2022.104340. Epub 2022 Nov 7. PMID: 36356476; PMCID: PMC9649370.
  136. Gu L, Chen J, Yang Y, Zhang Y, Tian Y, Jiang J, Zhou D, Liao L. Data- independent acquisition mass spectrometry identification of extracellular vesicle biomarkers for gastric adenocarcinoma. Front Oncol. 2022 Nov 24;12:1051450. doi: 10.3389/fonc.2022.1051450. PMID: 36505781; PMCID: PMC9731329.
  137. Lu X, Fu Y, Gu L, Zhang Y, Liao AY, Wang T, Jia B, Zhou D, Liao L. Integrated proteome and phosphoproteome analysis of gastric adenocarcinoma reveals molecular signatures capable of stratifying patient outcome. Mol Oncol. 2023 Feb;17(2):261-283. doi: 10.1002/1878-0261.13361. Epub 2022 Dec 29. PMID: 36520032; PMCID: PMC9892830.
  138. Chen Y, Cai G, Jiang J, He C, Chen Y, Ding Y, Lu J, Zhao W, Yang Y, Zhang Y, Wu G, Wang H, Zhou Z, Teng L. Proteomic profiling of gastric cancer with peritoneal metastasis identifies a protein signature associated with immune microenvironment and patient outcome. Gastric Cancer. 2023 Jul;26(4):504-516. doi: 10.1007/s10120-023-01379-0. Epub 2023 Mar 17. PMID: 36930369; PMCID: PMC10284991.